Sector revisions Charles River Laboratories International, Inc. Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate 20:35:35 17/09/2026 +03			5-day change	1st Jan Change
248.40 ^EUR	+4.59%		-0.13%	+38.84%

04:24pm	Charles River Laboratories International Introduces Rapid Cell Banking Programs with Next-Generation Sequencing Characterization	CI
03:25pm	Argus Research Adjusts Charles River Laboratories International PT to $330 From $250, Maintains Buy Rating	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
LONZA GROUP AG		23
IQVIA HOLDINGS INC.		18
REVOLUTION MEDICINES, INC.		20
BEONE MEDICINES AG		28
CELLTRION, INC.		22
MEDPACE HOLDINGS, INC.		12
ASCENDIS PHARMA A/S	-	20
EUROFINS SCIENTIFIC SE		14
ICON PUBLIC LIMITED COMPANY		16
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		14
TEMPUS AI, INC.		17
BIO-TECHNE CORPORATION		11
PHARMARON BEIJING CO., LTD.		11
ABIVAX		7
KYMERA THERAPEUTICS, INC.		22
PROTAGONIST THERAPEUTICS, INC.		13
GENSCRIPT BIOTECH CORPORATION		7
QIAGEN N.V.		15
PRAXIS PRECISION MEDICINES, INC.		19
Average		16
Weighted average by Cap.		19